Sort
15,440 grants matching “organoids”
Core C: Sphingolipid Cancer Animal Pathology Core
$218,041Ashley Jones Snider · State University New York Stony Brook · P01 · FY2021 · CA
Core C: Sphingolipid Cancer Animal Pathology Core
$218,039Ashley Jones Snider · State University New York Stony Brook · P01 · FY2023 · CA
Inter-tissue and -individual variability in responses to mixtures
$218,019Ivan Rusyn · Texas A&M University · P42 · FY2021 · ES
Integrative Health Sciences Facility Core
$217,974Ivan Rusyn · Texas A&M University · P30 · FY2019 · ES
Comparing NK cell profiles within melanoma tumors and pregnancy: Implications for novel immunotherapies
$217,863Paul John Norman · University Of Colorado Denver · R21 · FY2025 · CA
Investigating the contribution of cellular senescence to the efficacy of radiation therapy.
$217,814Paul Bernard Romesser · Sloan-Kettering Inst Can Research · K08 · FY2025 · CA
Determining the role of tissue stiffness in the development of Alzheimer's disease pathology
$217,710Dae Won Park · University Of Colorado Denver · R21 · FY2023 · AG
Project 3: Immune Checkpoint Inhibition Therapy Enhanced by Integrated Photodynamic Treatment and Image Guidance in Preclinical Models of Pancreatic Cancer
$217,561Tayyaba Hasan · Massachusetts General Hospital · P01 · FY2024 · CA
ARID3a, a repressor in aged kidney progenitors?
$217,500Carol F Webb · University Of Oklahoma Hlth Sciences Ctr · R21 · FY2022 · AG
Mechanisms of immune control of intratumor heterogeneity and clonal competition
$217,410Flaminia Talos · State University New York Stony Brook · R21 · FY2022 · CA
CANcer Cachexia Action Network/CANCAN
$217,311Mariam Jamal-Hanjani · University College London · OT2 · FY2022 · CA
Preclinical Models and Therapeutics Core
$217,223Giorgio Inghirami · New York University School Of Medicine · P01 · FY2025 · CA
The experience of human subjects with brain organoid research
$217,214Kate E. Macduffie · Seattle Children'S Hospital · R00 · FY2024 · MH
CDK4/6 inhibition: a novel therapeutic strategy for GNAS-mutant gastrointestinal malignancies
$217,163Andrew M Lowy · University Of California, San Diego · R21 · FY2023 · CA
Targeting the MICAL2 signaling axis in pancreatic cancer
$217,163Andrew M Lowy · University Of California, San Diego · R21 · FY2023 · CA
Project 3: Combination inhibition of ERK for pancreatic cancer treatment
$217,154Andrea Wang-Gillam · Washington University · P50 · FY2018 · CA
Resveratrol-mediated regulation of inflammatory pathways in Autism spectrum disorders
$217,135Sofia Beatriz Lizarraga · University Of South Carolina At Columbia · P20 · FY2019 · GM
Cancer Cell-Extrinsic and Intrinsic Regulators of Tumorigenesis
$217,004Andrew Ji · Icahn School Of Medicine At Mount Sinai · K08 · FY2024 · CA
Cancer Cell-Extrinsic and Intrinsic Regulators of Tumorigenesis
$217,004Andrew Ji · Icahn School Of Medicine At Mount Sinai · K08 · FY2023 · CA
Cancer Cell-Extrinsic and Intrinsic Regulators of Tumorigenesis
$217,004Andrew Ji · Icahn School Of Medicine At Mount Sinai · K08 · FY2022 · CA
Cancer Cell-Extrinsic and Intrinsic Regulators of Tumorigenesis
$217,004Andrew Ji · Icahn School Of Medicine At Mount Sinai · K08 · FY2021 · CA
Cancer Cell-Extrinsic and Intrinsic Regulators of Tumorigenesis
$217,004Andrew Ji · Icahn School Of Medicine At Mount Sinai · K08 · FY2025 · CA
Mouse Models and Cell Systems Core
$216,983Patricia Outeda Garcia · University Of Maryland Baltimore · U54 · FY2025 · DK
Center for Open Bioimage Analysis
$216,976Anne E. Carpenter · Broad Institute, Inc. · P41 · FY2024 · GM
A Novel Assay to Individualize Resensitization of Iodine-Refractory Thyroid Cancer
$216,862Guillem Pratx · Stanford University · R61 · FY2023 · CA